| Catherine A Nelson, DO | |
|
1830 State Highway 9, Decorah, IA 52101-7301 | |
| (563) 382-3140 | |
| Not Available |
| Full Name | Catherine A Nelson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 1830 State Highway 9, Decorah, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881004042 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Croix Hospice | Strawberry point, IA | Hospice |
| Winneshiek Medical Center Hospice | Decorah, IA | Hospice |
| Winneshiek Medical Center | Decorah, IA | Hospital |
| Veterans Memorial Hospital | Waukon, IA | Hospital |
| Gundersen Lutheran Medical Center | La crosse, WI | Hospital |
| Good Samaritan Society - Waukon | Waukon, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gundersen Regional Clinics, Llc | 8820450919 | 48 |
| Gundersen Clinic Ltd | 9638082779 | 359 |
News Archive
NPS MedicineWise has this week launched a new health professional program on ankle and knee imaging—developed in conjunction with musculoskeletal experts and in line with RANZCR, Australian Physiotherapy Association and Australian College of Nursing Choosing Wisely Australia recommendations and RACGP clinical guidance for MRI referral.
Atopix Therapeutics Ltd, a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the recruitment of the first patient in a six month Phase 2 clinical trial of its lead compound OC459 in moderate-to-severe atopic dermatitis (eczema).
A pilot study testing wastewater from buildings as a surveillance method for COVID-19 found it to be a feasible method for detecting positive cases in highly occupied settings like dormitories.
Simcyp Limited, experts in simulating how the body deals with new drugs in development, today announces that it has won a Queen's Award for Enterprise. The award has been made in the Innovation category and reflects Simcyp's continuous development of modelling and simulation software for evaluating drugs in the safety of a computer.
› Verified 1 days ago
| Entity Name | Gundersen Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20040130000561 |
News Archive
NPS MedicineWise has this week launched a new health professional program on ankle and knee imaging—developed in conjunction with musculoskeletal experts and in line with RANZCR, Australian Physiotherapy Association and Australian College of Nursing Choosing Wisely Australia recommendations and RACGP clinical guidance for MRI referral.
Atopix Therapeutics Ltd, a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the recruitment of the first patient in a six month Phase 2 clinical trial of its lead compound OC459 in moderate-to-severe atopic dermatitis (eczema).
A pilot study testing wastewater from buildings as a surveillance method for COVID-19 found it to be a feasible method for detecting positive cases in highly occupied settings like dormitories.
Simcyp Limited, experts in simulating how the body deals with new drugs in development, today announces that it has won a Queen's Award for Enterprise. The award has been made in the Innovation category and reflects Simcyp's continuous development of modelling and simulation software for evaluating drugs in the safety of a computer.
› Verified 1 days ago
| Entity Name | Gundersen Regional Clinics, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699461558 PECOS PAC ID: 8820450919 Enrollment ID: O20230822002401 |
News Archive
NPS MedicineWise has this week launched a new health professional program on ankle and knee imaging—developed in conjunction with musculoskeletal experts and in line with RANZCR, Australian Physiotherapy Association and Australian College of Nursing Choosing Wisely Australia recommendations and RACGP clinical guidance for MRI referral.
Atopix Therapeutics Ltd, a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the recruitment of the first patient in a six month Phase 2 clinical trial of its lead compound OC459 in moderate-to-severe atopic dermatitis (eczema).
A pilot study testing wastewater from buildings as a surveillance method for COVID-19 found it to be a feasible method for detecting positive cases in highly occupied settings like dormitories.
Simcyp Limited, experts in simulating how the body deals with new drugs in development, today announces that it has won a Queen's Award for Enterprise. The award has been made in the Innovation category and reflects Simcyp's continuous development of modelling and simulation software for evaluating drugs in the safety of a computer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Catherine A Nelson, DO 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 782-7300 | Catherine A Nelson, DO 1830 State Highway 9, Decorah, IA 52101-7301 Ph: (563) 382-3140 |
News Archive
NPS MedicineWise has this week launched a new health professional program on ankle and knee imaging—developed in conjunction with musculoskeletal experts and in line with RANZCR, Australian Physiotherapy Association and Australian College of Nursing Choosing Wisely Australia recommendations and RACGP clinical guidance for MRI referral.
Atopix Therapeutics Ltd, a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the recruitment of the first patient in a six month Phase 2 clinical trial of its lead compound OC459 in moderate-to-severe atopic dermatitis (eczema).
A pilot study testing wastewater from buildings as a surveillance method for COVID-19 found it to be a feasible method for detecting positive cases in highly occupied settings like dormitories.
Simcyp Limited, experts in simulating how the body deals with new drugs in development, today announces that it has won a Queen's Award for Enterprise. The award has been made in the Innovation category and reflects Simcyp's continuous development of modelling and simulation software for evaluating drugs in the safety of a computer.
› Verified 1 days ago
Eric William Svestka, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 | |
Paul G Wenner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery Street, Winneshiek Medical Center, Decorah, IA 52101 Phone: 563-382-2911 Fax: 563-387-3102 | |
Lisa A. Zittergruen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 Fax: 563-382-4143 | |
Kent William Svestka, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 | |
Bill R Withers, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1830 State Highway 9, Decorah, IA 52101 Phone: 563-382-3140 | |
Kevin L Sand, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-9671 Fax: 563-382-5015 | |
Kurt A Swanson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1830 State Highway 9, Decorah, IA 52101 Phone: 563-382-3140 |